In vitro metabolism of α7 neuronal nicotinic receptor agonist AZD0328 and enzyme identification for its N-oxide metabolite

References

• Bjornsson TD, Callaghan JT, Einolf HJ, Fischer V, Gan L, Grimm S, Kao J, King SP, Miwa G, Ni L, Kumar G, McLeod J, Obach RS, Roberts S, Roe A, Shah A, Snikeris F, Sullivan JT, Tweedie D, Vega JM, Walsh J, Wrighton SA; Pharmaceutical Research and Manufacturers of America (PhRMA) Drug Metabolism/Clinical Pharmacology Technical Working Group; FDA Center for Drug Evaluation and Research (CDER). (2003). The conduct of in vitro and in vivo drug-drug interaction studies: a Pharmaceutical Research and Manufacturers of America (PhRMA) perspective. Drug Metab Dispos 31:815–832.
   PubMed Web of Science ®Google Scholar
• Bjugstad KB, Mahnir VM, Kem WR, Socci DJ, Arendash GW (1996) Long-term treatment with GTS-21 or nicotine enhances water maze performance in aged rats without affecting the density of nicotinic receptor subtypes in neocortex. Drug Dev Res 39:19–28.
   Web of Science ®Google Scholar
• Brookmeyer R, Johnson E, Ziegler-Graham K, Arrighi HM. (2007). Forecasting the global burden of Alzheimer′s disease. Alzheimers Dement 3:186–191.
   PubMed Web of Science ®Google Scholar
• Burghaus L, Schütz U, Krempel U, de Vos RA, Jansen Steur EN, Wevers A, Lindstrom J, Schröder H. (2000). Quantitative assessment of nicotinic acetylcholine receptor proteins in the cerebral cortex of Alzheimer patients. Brain Res Mol Brain Res 76:385–388.
   PubMedGoogle Scholar
• Cashman JR, Zhang J. (2006). Human flavin-containing monooxygenases. Annu Rev Pharmacol Toxicol 46:65–100.
   PubMed Web of Science ®Google Scholar
• Damani LA, Shaker MS, Crooks PA, Godin CS, Nwosu C. (1986). N-methylation and quaternization of pyridine in vitro by rabbit lung, liver and kidney N-methyltransferases: an S-adenosyl-L-methionine-dependent reaction. Xenobiotica 16:645–650.
   PubMed Web of Science ®Google Scholar
• de Graaf C, Vermeulen NP, Feenstra KA. (2005). Cytochrome p450 in silico: an integrative modeling approach. J Med Chem 48:2725–2755.
   PubMed Web of Science ®Google Scholar
• Guan ZZ, Zhang X, Ravid R, Nordberg A. (2000). Decreased protein levels of nicotinic receptor subunits in the hippocampus and temporal cortex of patients with Alzheimer′s disease. J Neurochem 74:237–243.
   PubMed Web of Science ®Google Scholar
• Hawes EM. (1998). N+-glucuronidation, a common pathway in human metabolism of drugs with a tertiary amine group. Drug Metab Dispos 26:830–837.
   PubMed Web of Science ®Google Scholar
• Kitagawa H, Takenouchi T, Azuma R, Wesnes KA, Kramer WG, Clody DE, Burnett AL. (2003). Safety, pharmacokinetics, and effects on cognitive function of multiple doses of GTS-21 in healthy, male volunteers. Neuropsychopharmacology 28:542–551.
   PubMed Web of Science ®Google Scholar
• Ko JW, Desta Z, Soukhova NV, Tracy T, Flockhart DA. (2000). In vitro inhibition of the cytochrome P450 (CYP450) system by the antiplatelet drug ticlopidine: potent effect on CYP2C19 and CYP2D6. Br J Clin Pharmacol 49:343–351.
   PubMed Web of Science ®Google Scholar
• Lin JH. (1998). Applications and limitations of interspecies scaling and in vitro extrapolation in pharmacokinetics. Drug Metab Dispos 26:1202–1212.
   PubMed Web of Science ®Google Scholar
• Lin JH, Wong BK. (2002). Complexities of glucuronidation affecting in vitro in vivo extrapolation. Curr Drug Metab 3:623–646.
   PubMed Web of Science ®Google Scholar
• Levin ED, Bettegowda C, Blosser J, Gordon J. (1999). AR-R17779, and alpha7 nicotinic agonist, improves learning and memory in rats. Behav Pharmacol 10:675–680.
   PubMed Web of Science ®Google Scholar
• Levin ED, McClernon FJ, Rezvani AH. (2006). Nicotinic effects on cognitive function: behavioral characterization, pharmacological specification, and anatomic localization. Psychopharmacology (Berl) 184:523–539.
   PubMed Web of Science ®Google Scholar
• Obach RS. (1999). Prediction of human clearance of twenty-nine drugs from hepatic microsomal intrinsic clearance data: An examination of in vitro half-life approach and nonspecific binding to microsomes. Drug Metab Dispos 27:1350–1359.
   PubMed Web of Science ®Google Scholar
• Olesen OV, Linnet K. (1999). Studies on the stereoselective metabolism of citalopram by human liver microsomes and cDNA-expressed cytochrome P450 enzymes. Pharmacology 59:298–309.
   PubMed Web of Science ®Google Scholar
• Pacifici GM, Franchi M, Bencini C, Repetti F, Di Lascio N, Muraro GB. (1988). Tissue distribution of drug-metabolizing enzymes in humans. Xenobiotica 18:849–856.
   PubMed Web of Science ®Google Scholar
• Parsons RB, Smith ML, Williams AC, Waring RH, Ramsden DB. (2002). Expression of nicotinamide N-methyltransferase (E.C. 2.1.1.1) in the Parkinsonian brain. J Neuropathol Exp Neurol 61:111–124.
   PubMed Web of Science ®Google Scholar
• Rezvani AH, Kholdebarin E, Brucato FH, Callahan PM, Lowe DA, Levin ED. (2009). Effect of R3487/MEM3454, a novel nicotinic alpha7 receptor partial agonist and 5-HT3 antagonist on sustained attention in rats. Prog Neuropsychopharmacol Biol Psychiatry 33:269–275.
   PubMed Web of Science ®Google Scholar
• Rini J, Szumlanski C, Guerciolini R, Weinshilboum RM. (1990). Human liver nicotinamide N-methyltransferase: ion-pairing radiochemical assay, biochemical properties and individual variation. Clin Chim Acta 186:359–374.
   PubMed Web of Science ®Google Scholar
• Shaffer CL, Gunduz M, Scialis RJ, Fang AF. (2007). Metabolism and disposition of a selective alpha(7) nicotinic acetylcholine receptor agonist in humans. Drug Metab Dispos 35:1188–1195.
   PubMed Web of Science ®Google Scholar
• Sydserff S, Sutton EJ, Song D, Quirk MC, Maciag C, Li C, Jonak G, Gurley D, Gordon JC, Christian EP, Doherty JJ, Hudzik T, Johnson E, Mrzljak L, Piser T, Smagin GN, Wang Y, Widzowski D, Smith JS. (2009). Selective alpha7 nicotinic receptor activation by AZD0328 enhances cortical dopamine release and improves learning and attentional processes. Biochem Pharmacol 78:880–888.
   PubMed Web of Science ®Google Scholar
• Tarditi A, Caricasole A, Terstappen G. (2009). Therapeutic targets for Alzheimer′s disease. Expert Opin Ther Targets 13:551–567.
   PubMed Web of Science ®Google Scholar
• Taly A, Corringer PJ, Guedin D, Lestage P, Changeux JP. (2009). Nicotinic receptors: allosteric transitions and therapeutic targets in the nervous system. Nat Rev Drug Discov 8:733–750.
   PubMed Web of Science ®Google Scholar
• Thomsen MS, Hansen HH, Timmerman DB, Mikkelsen JD. (2010). Cognitive improvement by activation of alpha7 nicotinic acetylcholine receptors: from animal models to human pathophysiology. Curr Pharm Des 16:323–343.
   PubMed Web of Science ®Google Scholar
• Zhou SF, Liu JP, Lai XS. (2009). Substrate specificity, inhibitors and regulation of human cytochrome P450 2D6 and implications in drug development. Curr Med Chem 16:2661–2805.
   PubMed Web of Science ®Google Scholar